Tuesday, April 7, 2026
27.3 C
Bengaluru

What’s the Mood of Indian Pharma? A Poll by MedicinMan

We are in the middle of huge crisis and uncertainty. The Covid-19 crisis is taking a toll on Indian Pharma Leaders. Many leaders are not sure – what is of critical importance at this time? What are they are supposed to do and how they are supposed to do it? There are enormous challenges that majority of leaders have not faced before.

  • Many leaders had to take a pay-cut, downsize their teams, and deliver bad news up and down the organization.
  • Working from home for months and feeling stressed because there is no light at the end of the tunnel.
  • What can you do to stay focused and upbeat during this prolonged uncertain time?
  • How can you learn to reframe the situation that you are facing?
  • Who can you vent your frustration and feelings to? And, what can you do to recharge when most of your usual outlets are not available?

Leading effectively — especially during a crisis, needs emotional maturity and patience. If you can’t retain your cool and composure in the face of frustration and adversity, you won’t be able to keep others in your team, calm.

While this is really difficult, how can we change our focus and think about it differently?

This is probably the biggest growth opportunity that you will ever have in your career, if only you can manage through this and make sure your team weather this storm. Let’s discover the power of emotional intelligence in leadership, and challenge how leaders can develop this competency to not only improve self-management but also handle interpersonal relationships judiciously and empathetically.

Get an insight into the Emotional State of Indian Pharma professionals at the Digital Excellence Pharma Academy.

Register now for our webinar, “Leading with Emotional Intelligence” by Deep Bhandari on Wednesday 23rd September on https://www.credoweb.in/discussion/558/leading-with-emotional-intelligence?anchor=1167

Hot this week

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie

A Tale of Two Truths: Severance, Up in the...

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...
spot_img

Related Articles

spot_imgspot_img